Every morning, Rebecca Docherty logs on from her home near Edinburgh and begins writing lines of code. To most people, these cryptic-looking lines are indecipherable. But the AI models she builds help researchers sift through millions of molecules in search of tomorrow’s medicines or analyse brain scans that support preclinical research.
“One of the things I love most about my job is that it’s directly helping human health,” says Docherty, a senior scientist at the German biotech firm Evotec where she applies advanced computing in early-stage drug development (in silico testing).
